Bril A, Abadie C, Ben Baouali A, Maupoil V, Rochette L
Laboratoire de Physiopathologie et Pharmacologie Cardiovasculaire Experimentales, Facultés de Médecine et de Pharmacie, Dijon, France.
Pharmacology. 1993;46(1):23-32. doi: 10.1159/000139025.
Tricyclic antidepressant drugs may affect the cardiovascular system, principally in patients with preexisting cardiac disease. The present study was undertaken to compare the effects of amitriptyline and mianserin with those of tianeptine, an atypical tricyclic antidepressant drug, in rat isolated working heart subjected to a local myocardial ischemia. Coronary, aortic and cardiac flows, and heart rate remained stable during the whole preischemic period in control hearts. Ligation of the left main coronary artery induced a 50% decrease in coronary, aortic and cardiac flow without any change in heart rate. Reperfusion was characterized by the occurrence of ventricular arrhythmias (ventricular tachycardia and ventricular fibrillation) and by a marked reduction in cardiodynamic parameters. Amitriptyline (1 and 10 mumol/l) and mianserin (1 and 10 mumol/l) exhibited an antiarrhythmic activity against reperfusion arrhythmias. Tianeptine (1 and 10 mumol/l) was not able to reduce the incidence of reperfusion arrhythmias. Although tianeptine did not change heart rate, mianserin and amitriptyline induced a bradycardia. Mianserin and amitriptyline improved the cardiac recovery of cardiac function during reperfusion. The cardiodynamic parameters (coronary, aortic and cardiac flows) were not altered by tianeptine during the preischemic period. Furthermore, these parameters were similar to those observed in the control group both during ischemia and reperfusion. The beneficial effects of amitriptyline and mianserin observed in the setting of myocardial reperfusion were not associated with a reduced lipoperoxidation investigated by using an in vitro model in the presence or absence of a free-radical-generating system. The results of the present study indicate that the pronounced antiarrhythmic activities of mianserin and amitriptyline cannot be explained by an antiperoxidative action of these drugs.
三环类抗抑郁药可能会影响心血管系统,主要是在已有心脏疾病的患者中。本研究旨在比较阿米替林和米安色林与一种非典型三环类抗抑郁药噻奈普汀在大鼠离体工作心脏局部心肌缺血模型中的作用。在对照心脏的整个缺血前期,冠状动脉、主动脉和心脏血流量以及心率保持稳定。结扎左冠状动脉主干导致冠状动脉、主动脉和心脏血流量减少50%,而心率无任何变化。再灌注的特征是出现室性心律失常(室性心动过速和心室颤动)以及心脏动力学参数显著降低。阿米替林(1和10 μmol/L)和米安色林(1和10 μmol/L)对再灌注心律失常表现出抗心律失常活性。噻奈普汀(1和10 μmol/L)不能降低再灌注心律失常的发生率。尽管噻奈普汀不改变心率,但米安色林和阿米替林会引起心动过缓。米安色林和阿米替林改善了再灌注期间心脏功能的恢复。在缺血前期,噻奈普汀未改变心脏动力学参数(冠状动脉、主动脉和心脏血流量)。此外,在缺血和再灌注期间,这些参数与对照组观察到的参数相似。在心肌再灌注情况下观察到的阿米替林和米安色林的有益作用与使用体外模型在有或无自由基生成系统存在的情况下研究的脂质过氧化减少无关。本研究结果表明,米安色林和阿米替林明显的抗心律失常活性不能用这些药物的抗过氧化作用来解释。